Catégorie : News Releases

GlycoNet releases its 2022-2023 Corporate Report

GlycoNet releases its 2022-2023 Corporate Report

The report encapsulates a comprehensive overview of the network’s achievements, breakthroughs, and collaborations in the field of glycomics throughout the past year.

Within the report, readers will gain insight into the cutting-edge research and advancements made by GlycoNet, a collaborative effort involving scientists, researchers, and experts from academia, industry, and government institutions. It delves into the pioneering discoveries in glycobiology, highlighting the innovative applications and technologies that have emerged within the network.

Senator Paula Simons gets the sweet scoop on GlycoNet and glycomics

Senator Paula Simons gets the sweet scoop on GlycoNet and glycomics

Senator Paula Simons recently toured GlycoNet at the University of Alberta, exploring the realm of glycomics. The visit highlighted GlycoNet’s pivotal role in advancing glycomics and its transformative impact across One Health domains, underlined by discussions with GlycoNet’s CEO, Dr. Elizabeth Nanak.

The tour of cutting-edge labs showcased passionate researchers driving innovation in glycomics, and interactions with start-ups like 48Hour Discovery shed light on drug discovery advancements. This visit emphasized the value of such engagements, illustrating the shared commitment to a thriving future and the potential for collaborative efforts to elevate healthcare and nurture a diverse bioeconomy.

A Tour of the GlycoNet facilities with the Honourable Randy Boissonnault

A Tour of the GlycoNet facilities with the Honourable Randy Boissonnault

A significant gathering of researchers, industry experts, and rising stars in glycomics recently took place in Edmonton, Alberta with the Honourable Randy Boissonnault, focusing on advancements and current trends in the field.

GlycoNet Scientific Director and PlantForm awarded grant to enable commercial-scale production of protein drugs

GlycoNet Scientific Director and PlantForm awarded grant to enable commercial-scale production of protein drugs

The NSERC Alliance Grant will support the advancement of glycoengineering technology for plant-derived proteins.

fr_CAFrench
Remonter en haut de la page